首页> 外文期刊>The International journal of drug policy >Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis
【24h】

Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis

机译:常规选择性选择性艾滋病毒/ HCV筛选对注射器服务计划测试摄取的影响:中断时间序列分析

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Hepatitis C (HCV) is the most common infectious disease among people who inject drugs (PWID). Engaging PWID in harm reduction services, such as syringe service programs (SSPs), is critical to reduce HCV and HIV transmission. Additionally, testing for HIV and HCV among PWID is important to improve diagnosis and linkage to care. On March 1, 2018, Florida's only legal SSP implemented bundled opt-out HIV/HCV testing at enrollment. We aimed to examine the differences in HIV/HCV testing uptake before and after the implementation of the opt-out testing policy.
机译:背景:丙型肝炎(HCV)是注射药物(PWID)人群中最常见的传染病。让PWID参与减少伤害的服务,如注射器服务计划(SSP),对于减少HCV和HIV传播至关重要。此外,在PWID中检测HIV和HCV对于改善诊断和与护理的联系非常重要。2018年3月1日,佛罗里达州唯一的合法SSP在注册时实施捆绑式选择退出HIV/HCV检测。我们的目的是研究在实施选择退出检测政策之前和之后,HIV/HCV检测摄入的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号